Serological diagnosis of toxoplasmosis: evaluation of the commercial test recomLine Toxoplasma IgG immunoblot (Mikrogen) based on recombinant antigens.
- DOI
- 10.1051/parasite/2022050
- Published
- 2022
- Container
- Parasite (Paris, France)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1051/parasite/2022050,
title = {Serological diagnosis of toxoplasmosis: evaluation of the commercial test recomLine Toxoplasma IgG immunoblot (Mikrogen) based on recombinant antigens.},
author = {Jean-Pierre V and Miozzo J and Fricker-Hidalgo H and Garnaud C and Robert MG and Pelloux H and Brenier-Pinchart MP},
year = {2022},
journal = {Parasite (Paris, France)},
doi = {10.1051/parasite/2022050},
url = {https://doi.org/10.1051/parasite/2022050}
}RIS
TY - JOUR TI - Serological diagnosis of toxoplasmosis: evaluation of the commercial test recomLine Toxoplasma IgG immunoblot (Mikrogen) based on recombinant antigens. AU - Jean-Pierre V AU - Miozzo J AU - Fricker-Hidalgo H AU - Garnaud C AU - Robert MG AU - Pelloux H AU - Brenier-Pinchart MP PY - 2022 JO - Parasite (Paris, France) DO - 10.1051/parasite/2022050 UR - https://doi.org/10.1051/parasite/2022050 ER -
APA
V, J., J, M., H, F., C, G., MG, R., H, P., & MP, B. (2022). Serological diagnosis of toxoplasmosis: evaluation of the commercial test recomLine Toxoplasma IgG immunoblot (Mikrogen) based on recombinant antigens.. Parasite (Paris, France). https://doi.org/10.1051/parasite/2022050
Source records
- pubmed · retrieved 2026-09-26T23:13:10.539Z